Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)?

Coker, R; (2002) Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)? The international journal of tuberculosis and lung disease, 6 (8). pp. 649-50. ISSN 1027-3719 https://researchonline.lshtm.ac.uk/id/eprint/17607

Permanent Identifier

Use this permanent URL when citing or linking to this resource.

https://researchonline.lshtm.ac.uk/id/eprint/17607

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Google Scholar